Botulinum toxin in patients at‐risk for bladder augmentation: Durable impact or kicking the can?
Sign Up to like & getrecommendations! Published in 2022 at "Neurourology and Urodynamics"
DOI: 10.1002/nau.24962
Abstract: Deferring bladder augmentation (BA) may be desirable in a pediatric neurogenic bladder (NGB) with worsening compliance, but prior studies have questioned whether onabotulinum toxin A (BTX) demonstrates durable improvement in compliance. We present our overall… read more here.
Keywords: risk; botulinum toxin; augmentation; bladder augmentation ... See more keywords